BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10849555)

  • 1. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity.
    Schendel DJ; Falk CS; Nössner E; Maget B; Kressenstein S; Urlinger S; Tampé R; Gansbacher B
    Gene Ther; 2000 Jun; 7(11):950-9. PubMed ID: 10849555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
    Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
    Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
    Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
    Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
    Schendel DJ; Frankenberger B; Jantzer P; Cayeux S; Nöbetaner E; Willimsky G; Maget B; Pohla H; Blankenstein T
    Gene Ther; 2000 Dec; 7(23):2007-14. PubMed ID: 11175312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.
    Seliger B; Hammers S; Höhne A; Zeidler R; Knuth A; Gerharz CD; Huber C
    Clin Cancer Res; 1997 Apr; 3(4):573-8. PubMed ID: 9815722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.
    Momburg F; Ortiz-Navarrete V; Neefjes J; Goulmy E; van de Wal Y; Spits H; Powis SJ; Butcher GW; Howard JC; Walden P
    Nature; 1992 Nov; 360(6400):174-7. PubMed ID: 1299222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.
    Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
    Johnsen A; France J; Sy MS; Harding CV
    Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.
    Kurokawa T; Oelke M; Mackensen A
    Int J Cancer; 2001 Mar; 91(6):749-56. PubMed ID: 11275975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.
    Seliger B; Höhne A; Jung D; Kallfelz M; Knuth A; Jaeger E; Bernhard H; Momburg F; Tampé R; Huber C
    Exp Hematol; 1997 Jul; 25(7):608-14. PubMed ID: 9216736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses: lessons from recurrent tumors.
    Zheng P; Sarma S; Guo Y; Liu Y
    Cancer Res; 1999 Jul; 59(14):3461-7. PubMed ID: 10416611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
    Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules.
    Arnold D; Driscoll J; Androlewicz M; Hughes E; Cresswell P; Spies T
    Nature; 1992 Nov; 360(6400):171-4. PubMed ID: 1436094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.